T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Coursera
COUR
$1.3B
| $1.53M | ﹤0.01% |
271,261
+116,951
| +76% | +$664K |
|
2127
ASE Group
ASX
$115B
| $1.53M | ﹤0.01% |
+33,842
| New | +$1.14M |
|
2128
Takeda Pharmaceutical
TAK
$59.9B
| $1.52M | ﹤0.01% |
94,848
-45,345
| -32% | -$750K |
|
|
DEA
2129
Easterly Government Properties
DEA
$1.08B
| $1.52M | ﹤0.01% |
60,874
+13,455
| +28% | +$316K |
|
2130
Utah Medical Products
UTMD
$235M
| $1.51M | ﹤0.01% |
21,938
+3,638
| +20% | +$242K |
|
2131
iShares 0-3 Month Treasury Bond ETF
SGOV
$112B
| $1.51M | ﹤0.01% |
15,000
| – | – |
|
2132
Hovnanian Enterprises
HOV
$672M
| $1.5M | ﹤0.01% |
10,558
+1,727
| +20% | +$197K |
|
2133
NextDecade
NEXT
$1.76B
| $1.5M | ﹤0.01% |
198,508
+27,779
| +16% | +$220K |
|
2134
CareDx
CDNA
$3.26B
| $1.49M | ﹤0.01% |
52,291
+5,290
| +11% | +$115K |
|
2135
NextNav
NN
$2.39B
| $1.49M | ﹤0.01% |
83,394
+13,275
| +19% | +$257K |
|
2136
Douglas Dynamics
PLOW
$912M
| $1.48M | ﹤0.01% |
27,484
+2,690
| +11% | +$124K |
|
|
ALX
2137
Alexander's
ALX
$1.26B
| $1.48M | ﹤0.01% |
5,373
+910
| +20% | +$227K |
|
2138
Cadre Holdings
CDRE
$1.13B
| $1.48M | ﹤0.01% |
51,920
+14,856
| +40% | +$448K |
|
2139
Tecnoglass Holdings
TGLS
$1.54B
| $1.48M | ﹤0.01% |
31,577
+5,084
| +19% | +$220K |
|
2140
Butterfly Network
BFLY
$2.48B
| $1.48M | ﹤0.01% |
175,183
+25,645
| +17% | +$133K |
|
|
PPTA
2141
Perpetua Resources
PPTA
$2.8B
| $1.47M | ﹤0.01% |
70,835
+9,311
| +15% | +$253K |
|
2142
CONMED
CNMD
$1.34B
| $1.47M | ﹤0.01% |
44,888
+8,800
| +24% | +$317K |
|
2143
Ecovyst
ECVT
$1.1B
| $1.47M | ﹤0.01% |
117,964
+10,490
| +10% | +$142K |
|
2144
Blackbaud
BLKB
$1.92B
| $1.47M | ﹤0.01% |
49,513
+5,779
| +13% | +$190K |
|
2145
Grocery Outlet
GO
$1.1B
| $1.46M | ﹤0.01% |
146,573
+13,168
| +10% | +$108K |
|
2146
AMERISAFE
AMSF
$433M
| $1.46M | ﹤0.01% |
43,074
+9,070
| +27% | +$287K |
|
2147
Winnebago Industries
WGO
$755M
| $1.45M | ﹤0.01% |
46,454
+6,887
| +17% | +$210K |
|
|
TBPH
2148
DELISTED
Theravance Biopharma
TBPH
| $1.45M | ﹤0.01% |
85,263
+10,123
| +13% | +$168K |
|
2149
Ingles Markets
IMKTA
$1.58B
| $1.45M | ﹤0.01% |
16,331
+1,988
| +14% | +$178K |
|
2150
Under Armour Class C
UA
$1.83B
| $1.45M | ﹤0.01% |
232,607
+79,965
| +52% | +$461K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.